Core Viewpoint - He Eye Hospital (301103) expects a net profit attributable to shareholders of 24 million to 36 million for 2025, representing a year-on-year growth of 187.60% to 231.40% [1] Group 1: Performance Improvement - The company has achieved a turnaround from loss to profit during the reporting period, driven by business structure optimization, effective cost control, and the disposal of inefficient assets [1] - Significant enhancement in profitability is attributed to the continuous optimization of the business structure, with a focus on high-margin refractive and optical businesses [1] Group 2: Cost and Efficiency Management - The company has implemented refined operational management, achieving cost reduction and efficiency improvement through centralized procurement optimization, supply chain efficiency enhancement, and digital operations [1] - These measures have contributed to the overall improvement in profitability [1] Group 3: Asset Optimization - The company has actively integrated, adjusted, or divested certain business units that have long-term poor performance or weak strategic synergy, further optimizing asset allocation efficiency [1]

Core Viewpoint - The company is expected to turn a profit in 2025, reversing previous losses due to optimized business structure, effective cost control, and the clearing of inefficient assets [1][2]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [1]. - The company anticipates a turnaround from loss to profit, indicating a positive shift in financial performance [1]. Group 2: Reasons for Performance Change - Continuous optimization of the business structure has driven growth, particularly in high-margin refractive and optical businesses [2]. - Significant results from cost and expense management have been achieved through refined operational management, centralized procurement, and enhanced supply chain efficiency [2]. - The company has actively integrated, adjusted, or divested underperforming business units to improve asset allocation efficiency [2]. Group 3: Additional Information - The performance forecast is based on preliminary calculations by the company's finance department and has not yet been audited by an accounting firm [3]. - Final financial data will be disclosed in the company's 2025 annual report [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company experienced a decline in both coal volume and price in H1 2025, leading to a significant drop in revenue and profit. The report emphasizes the importance of asset injection and the clearance of inefficient assets [2][4] - The company reported H1 2025 revenue of 2.38 billion yuan, down 38.9% year-on-year, and a net profit attributable to shareholders of -130 million yuan, down 117% year-on-year. The report has adjusted profit forecasts for 2025-2027, expecting net profits of 110 million, 330 million, and 710 million yuan respectively [2][3] Financial Performance Summary - In H1 2025, the company produced 4.768 million tons of raw coal, a decrease of 3.5% year-on-year, with sales of 3.55 million tons of commercial coal, down 7.7% year-on-year. In Q2 2025, raw coal production was 2.402 million tons, an increase of 1.5% quarter-on-quarter [3] - The average selling price of coal in H1 2025 was 662.2 yuan per ton, down 30.6% year-on-year, while the cost per ton was 567.2 yuan, up 1.6% year-on-year [3] - The gross profit per ton of coal in H1 2025 was 94.9 yuan, down 76.1% year-on-year, with a gross margin of 14.3%, down 27.2 percentage points year-on-year [3] Asset Management and Future Outlook - The company has decided to deregister a loss-making subsidiary, which is expected to reduce losses and optimize the profit structure. This move is anticipated to enhance the profitability of the coal business when coal prices recover [4] - The company confirmed the successful operation of a new power generation unit, which is expected to generate approximately 5 billion kilowatt-hours annually, providing a strong support for long-term stable development [4] - The report highlights the company's commitment to asset injection, with expectations for significant growth in resource reserves and production capacity if transactions materialize [4]